Congenital Hematological Disorder Completed Phase 1 Trials for Eptacog alfa pegol (activated) (DB11661)

Back to Congenital Hematological Disorder

Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00951873A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male VolunteersTreatment
NCT00922792Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and BTreatment